Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Baligar

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Hepatology International|July 24, 2015
Bone marrow stem-cell therapy for genetic and chronic liver diseasesVeena Kochat, Prakash Baligar, Rakhi Maiwall, et al.
Biomedical Materials (Bristol, England)|October 20, 2023
Gelatin scaffold ameliorates proliferation & stem cell differentiation into the hepatic like cell and support liver regeneration in partial-hepatectomized mice modelKshama Kumari, Simran Tandon, Sourabh Ghosh, et al.
Stem Cell Research & Therapy|July 9, 2015
Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cellsVeena Kochat, Sumod Kanjirakkuzhiyil, Prakash Baligar, et al.
Life Sciences|November 18, 2023
Molecular heterogeneity in prostate cancer and the role of targeted therapySabiha Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Stem Cells (Dayton, Ohio)|September 22, 2015
Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver CirrhosisPrakash Baligar, Snehasish Mukherjee, Veena Kochat, et al.
Chemico-Biological Interactions|October 22, 2017
Human kidney stone matrix: Latent potential to restrain COM induced cytotoxicity and inflammatory responseShifa Narula, Simran Tandon, Prakash Baligar, et al.
Plos One|March 23, 2017
JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factorsVeena Kochat, Zaffar Equbal, Prakash Baligar, et al.
Current Pharmaceutical Design|October 20, 2020
Stem Cell Based Preclinical Drug Development and Toxicity PredictionDhruv Kumar, Prakash Baligar, Rajpal Srivastav, et al.
Seminars in Cancer Biology|June 26, 2023
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancerSamarth Kansara, Agrata Singh, Abhishesh Kumar Badal, et al.
Transplantation and Cellular Therapy|March 15, 2024
Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant DiseasesSarita Rani Jaiswal, Mahak Agarwal, Gitali Bhagawati, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hepatology International|July 24, 2015
Bone marrow stem-cell therapy for genetic and chronic liver diseasesVeena Kochat, Prakash Baligar, Rakhi Maiwall, et al.
Biomedical Materials (Bristol, England)|October 20, 2023
Gelatin scaffold ameliorates proliferation & stem cell differentiation into the hepatic like cell and support liver regeneration in partial-hepatectomized mice modelKshama Kumari, Simran Tandon, Sourabh Ghosh, et al.
Stem Cell Research & Therapy|July 9, 2015
Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cellsVeena Kochat, Sumod Kanjirakkuzhiyil, Prakash Baligar, et al.
Life Sciences|November 18, 2023
Molecular heterogeneity in prostate cancer and the role of targeted therapySabiha Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Stem Cells (Dayton, Ohio)|September 22, 2015
Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver CirrhosisPrakash Baligar, Snehasish Mukherjee, Veena Kochat, et al.
Chemico-Biological Interactions|October 22, 2017
Human kidney stone matrix: Latent potential to restrain COM induced cytotoxicity and inflammatory responseShifa Narula, Simran Tandon, Prakash Baligar, et al.
Plos One|March 23, 2017
JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factorsVeena Kochat, Zaffar Equbal, Prakash Baligar, et al.
Current Pharmaceutical Design|October 20, 2020
Stem Cell Based Preclinical Drug Development and Toxicity PredictionDhruv Kumar, Prakash Baligar, Rajpal Srivastav, et al.
Seminars in Cancer Biology|June 26, 2023
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancerSamarth Kansara, Agrata Singh, Abhishesh Kumar Badal, et al.
Transplantation and Cellular Therapy|March 15, 2024
Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant DiseasesSarita Rani Jaiswal, Mahak Agarwal, Gitali Bhagawati, et al.
Pageof 2